InMed Pharmaceuticals Inc Financial Flexibility Index
InMed Pharmaceuticals Inc financial flexibility index. InMed Pharmaceuticals Inc (INM) has a Financial Flexibility Index of -3.60x as of June 2026. Free cash flow of $-7.03 Billion (operating CF $-7.03 Billion minus capex $5.49) represents -4% of total liabilities ($1.96 Billion). See INM free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of InMed Pharmaceuticals Inc (2001–2026)
Financial flexibility index of InMed Pharmaceuticals Inc from 2001 to 2026. Historical Financial Flexibility Index trend for InMed Pharmaceuticals Inc across 26 annual periods. Check InMed Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
InMed Pharmaceuticals Inc Financial Flexibility Index by Year (2001–2026)
InMed Pharmaceuticals Inc financial flexibility index by year from 2001 to 2026. Year-by-year free cash flow to debt coverage for InMed Pharmaceuticals Inc. For the full cash flow conversion analysis, see InMed Pharmaceuticals Inc (INM) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -4.42x | $-8.64 Billion | $-8.64 Billion | $1.96 Billion | ▼ -66.4% |
| 2025 | -2.66x | $-7.77 Million | $-7.77 Million | $2.92 Million | ▼ -36.3% |
| 2024 | -1.95x | $-6.98 Million | $-6.99 Million | $3.58 Million | ▲ +26.9% |
| 2023 | -2.67x | $-7.12 Million | $-7.28 Million | $2.67 Million | ▲ +18.1% |
| 2022 | -3.25x | $-15.54 Million | $-15.58 Million | $4.78 Million | ▲ +1.1% |
| 2021 | -3.29x | $-9.79 Million | $-9.79 Million | $2.97 Million | ▲ +13.6% |
| 2020 | -3.81x | $-7.33 Million | $-7.37 Million | $1.92 Million | ▲ +48.1% |
| 2019 | -7.34x | $-8.74 Million | $-8.77 Million | $1.19 Million | ▼ -44.1% |
| 2018 | -5.10x | $-3.63 Million | $-3.68 Million | $713.02K | ▲ +38.2% |
| 2017 | -8.25x | $-2.35 Million | $-2.37 Million | $284.24K | ▼ -877.4% |
| 2016 | -0.84x | $-385.19K | $-386.07K | $456.17K | ▲ +96.7% |
| 2015 | -25.64x | $-1.60 Million | $-1.61 Million | $62.51K | ▼ -181.1% |
| 2014 | -9.12x | $-639.35K | $-641.38K | $70.11K | ▼ -1042.9% |
| 2013 | -0.80x | $-39.26K | $-39.26K | $49.20K | ▲ +79.6% |
| 2012 | -3.92x | $-174.62K | $-174.62K | $44.59K | ▲ +67.8% |
| 2011 | -12.16x | $-562.05K | $-562.05K | $46.20K | ▼ -8272.6% |
| 2010 | -0.15x | $-195.42K | $-195.42K | $1.35 Million | ▼ -252.5% |
| 2009 | 0.10x | $100.48K | $100.48K | $1.05 Million | ▲ +115.6% |
| 2008 | -0.61x | $-926.30K | $-951.15K | $1.52 Million | ▲ +40.3% |
| 2007 | -1.02x | $-1.38 Million | $-1.40 Million | $1.35 Million | ▼ -101.2% |
| 2006 | -0.51x | $-577.40K | $-577.40K | $1.14 Million | ▼ -21.0% |
| 2005 | -0.42x | $-694.92K | $-702.23K | $1.66 Million | ▲ +30.0% |
| 2004 | -0.60x | $-468.75K | $-484.19K | $781.44K | ▲ +32.6% |
| 2003 | -0.89x | $-820.00K | $-844.62K | $921.99K | ▲ +94.1% |
| 2002 | -15.19x | $-1.13 Million | $-1.14 Million | $74.45K | ▼ -2661.5% |
| 2001 | 0.59x | $292.32K | $-471.69K | $493.02K | — |